Bayer AG Overview
Valuation check: BAYRY's P/E ratio is -22.74, below the Healthcare sector average of 26.36.
Get informed when a big investor buys or sells
+ Follow-22.74
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Bayer AG (BAYRY) currently reports a P/E ratio of -22.74. That is below the Healthcare sector average of 26.36. Use the charts on this page to explore Bayer AG's P/E ratio history and peer comparisons.
Bayer AG's P/E ratio of -22.74 is lower than the Healthcare sector average of 26.36. That is roughly 186.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Bayer AG's market price to a fundamental measure such as earnings, sales, or book value. At -22.74, BAYRY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -22.74, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 26.36. From there, open related valuation or income-statement pages for Bayer AG, and consider following BAYRY for alerts when major investors trade the stock.
Bayer AG is classified in the Healthcare sector. On P/E ratio, it currently shows -22.74 versus a sector average near 26.36. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BAYRY with unrelated industries.
